肝癌衍生生长因子对前列腺癌细胞增殖的影响及其机制
Effects and mechanisms of hepatoma-derived growth factor on the proliferation of prostate cancer cells

DOI: 10.6040/j.issn.1671-7554.0.2017.379

Keywords: 前列腺肿瘤,PI3K-AKT-mTOR信号通路,LNCap,细胞增殖,肝癌衍生生长因子,DU145,
Prostate neoplasm,PI3K-AKT-mTOR signaling way,LNCaP,Hepatoma-derived growth factor,Cell proliferation,DU145

Full-Text   Cite this paper   Add to My Lib

Abstract:

References

[1]	Lin YW, Li CF, Chen HY, et al. The expression and prognostic significance of hepatoma-derived growth factor in oral cancer[J]. Oral Oncol, 2012, 48(7): 629-635.
[2]	Shetty A, Dasari S, Banerjee S, et al. Hepatoma-derived growth factor: a survival-related protein in prostate oncogenesis and a potential target for vitamin K2[J]. Urol Oncol, 2016, 34(11): 483.e1-483.e8. doi: 10.1016/j.urolonc.2016.05.027.
[3]	Bao C, Wang J, Ma W, et al. HDGF: a novel jack-of-all-trades in cancer[J]. Future Oncol, 2014, 10(16): 2675-2685.
[4]	Everett AD, Narron JV, Stoops T, et al. Hepatoma-derived growth factor is a pulmonary endothelial cell-expressed angiogenic factor[J]. Am J Physiol Lung Cell Mol Physiol, 2004, 286(6): 1194-1201.
[5]	Mao J, Xu Z, Fang Y, et al. Hepatoma-derived growth factor involved in the carcinogenesis of gastric epithelial cells through promotion of cell proliferation by Erk1/2 activation[J]. Cancer Sci, 2008, 99(11): 2120-2127.
[6]	Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132.
[7]	Nakamura H, Kambe H, Egawa T, et al. Partial purification and characterization of human hepatoma-derived growth factor[J]. Clin Chim Acta, 1989, 183(3): 273-284.
[8]	Kishima Y, Yamamoto H, Izumoto Y, et al. Hepatoma-derived growth factor stimulates cell growth after translocation to the nucleus by nuclear localization signals[J]. J Biol Chem, 2002, 277(12): 10315-10322.
[9]	Yang Y, Zhen T, Zhang F, et al. p53 and hepatoma-derived growth factor expression and their clinicopathological association with Ewing family tumour[J]. J Clin Pathol, 2014, 67(3): 235-242.
[10]	Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012[J]. CA Cancer J Clin, 2015, 65(2): 87-108.
[11]	包慈航. 照射后成纤维细胞促进食管鳞癌EMT及HDGF表达的实验研究[D]. 济南:山东大学,2015.
[12]	Guo S, Liu HD, Liu YF, et al. Hepatoma-derived growth factor: a novel prognostic biomarker in intrahepatic cholangiocarcinoma[J]. Tumour Biol, 2015, 36(1): 353-364.
[13]	Enomoto H, Nakamura H, Liu W, et al. Hepatoma-derived growth factor: its possible involvement in the progression of hepatocellular carcinoma[J]. Int J Mol Sci, 2015, 16(6): 14086-14097.
[14]	Guo H, Li W, Zheng T, et al. MiR-195 targets HDGF to inhibit proliferation and invasion of NSCLC cells[J]. Tumour Biol, 2014, 35(9): 8861-8866.
[15]	Zhang J, Chen N, Qi J, et al. HDGF and ADAM9 are novel molecular staging biomarkers, prognostic biomarkers and predictive biomarkers for adjuvant chemotherapy in surgically resected stage I non-small cell lung cancer[J]. J Cancer Res Clin Oncol, 2014, 140(8): 1441-1449.
[16]	Liu XJ, Liu WL, Yang FM, et al. Hepatoma-derived growth factor predicts unfavorable prognosis of epithelial ovarian cancer[J]. Onco Targets Ther, 2015,8: 2101-2109. doi: 10.2147/OTT.S85660.
[17]	李大伟. HDGF在阴茎鳞状细胞癌中的表达及意义,HIF1A多态性与泌尿系统肿瘤的关系[D].济南:山东大学,2014.
[18]	Chen B, Huang T, Jiang J, et al. miR-141 suppresses proliferation and motility of gastric cancer cells by targeting HDGF[J]. Mol Cell Biochem, 2014, 388(1-2): 211-218.
[19]	Lian J, Tang J, Shi H, et al. Positive feedback loop of hepatoma-derived growth factor and beta-catenin promotes carcinogenesis of colorectal cancer[J]. Oncotarget, 2015, 6(30): 29357-29374.
[20]	Wang L, Jiang Q, Hua S, et al. High nuclear expression of HDGF correlates with disease progression and poor prognosis in human endometrial carcinoma[J]. Dis Markers, 2014, 2014: 298795. doi: 10.1155/2014/298795.
[21]	郭振英. HDGF在前列腺癌和乳腺癌生长、迁移、侵袭中的作用及机制研究[D].南京:南京医科大学,2011.
[22]	Chen SC, Kung ML, Hu TH, et al. Hepatoma-derived growth factor regulates breast cancer cell invasion by modulating epithelial-mesenchymal transition[J]. J Pathol, 2012, 228(2): 158-169.
[23]	Yang Y, Li H, Zhang F, et al. Clinical and biological significance of hepatoma-derived growth factor in Ewings sarcoma[J]. J Pathol, 2013, 231(3): 323-334.
[24]	Song Y, Hu Z, Long H, et al. A complex mechanism for HDGF-mediated cell growth, migration, invasion, and TMZ chemosensitivity in glioma[J]. J Neurooncol, 2014, 119(2): 285-295.
[25]	Kung ML, Tsai HE, Hu TH, et al. Hepatoma-derived growth factor stimulates podosome rosettes formation in NIH/3T3 cells through the activation of phosphatidylinositol 3-kinase/Akt pathway[J]. Biochem Biophys Res Commun, 2012, 425(2): 169-176.
[26]	Yu Y, Shen H, Yu H, et al. Systematic proteomic analysis of human hepotacellular carcinoma cells reveals molecular pathways and networks involved in metastasis[J]. Mol Biosyst, 2011, 7(6): 1908-1916.
[27]	Li SZ, Zhao YB, Cao WD, et al. The expression of hepatoma-derived growth factor in primary central nervous system lymphoma and its correlation with angiogenesis, proliferation and clinical outcome[J]. Med Oncol, 2013, 30(3): 622. doi: 10.1007/s12032-013-0622-8.

Full-Text